Service profile
KalVista Pharmaceuticals
Biopharmaceutical company developing oral plasma kallikrein inhibitors for hereditary angioedema and diabetic macular edema, advancing clinical trials for novel small molecule therapeutics.
About
What KalVista Pharmaceuticals is
Biopharmaceutical company developing oral plasma kallikrein inhibitors for hereditary angioedema and diabetic macular edema, advancing clinical trials for novel small molecule therapeutics.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://kalvistapharmaceuticals.com |
| Status coverage | Public status page |
| Founded | 2006 |
| Headquarters | Cambridge, Massachusetts, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...
Alternatives
